Helen Stephens Group
ABBV icon

Helen Stephens Group’s AbbVie ABBV Stock Holding History

Helen Stephens Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$380K Sell
1,454
-2
-0.1% -$513 0.06% 99
2026
Q2 		$366K Buy
1,456
+41
+3% +$8.82K 0.06% 102
2026
Q1 		$308K Sell
1,415
-456
-24% -$101K 0.06% 95
2025
Q4 		$427K Sell
1,871
-236
-11% -$53.8K 0.09% 75
2025
Q3 		$488K Buy
2,107
+791
+60% +$161K 0.11% 66
2025
Q2 		$244K Sell
1,316
-10
-0.8% -$1.86K 0.06% 80
2025
Q1 		$278K Sell
1,326
-43
-3% -$8.36K 0.08% 70
2024
Q4 		$243K Buy
1,369
+61
+5% +$11.2K 0.07% 77
2024
Q3 		$258K Buy
+1,308
New +$244K 0.08% 76

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return
Alecta Tjanstepension Omsesidigt
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $24.1B AUM 30.72% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Helen Stephens Group's ABBV Position: Q3 2026 in Review

Helen Stephens Group reduced its AbbVie (ABBV) stake by 0.14% in Q3 2026, selling an estimated $513 and leaving 1,454 shares worth $380K. The position accounts for 0.06% of the portfolio, ranked #99.

Helen Stephens Group first reported a position in ABBV in Q3 2024 and has held it in 9 quarters since. The position peaked at $488K in Q3 2025. 2,139 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Helen Stephens Group held 1,454 shares of AbbVie worth $380K as of Q3 2026.
  • Helen Stephens Group sold 2 AbbVie shares in Q3 2026, an estimated $513.
  • AbbVie made up 0.06% of Helen Stephens Group's portfolio in Q3 2026, its #99 holding.
  • Helen Stephens Group first reported a position in AbbVie in Q3 2024 and has held it in 9 quarters since.
  • Helen Stephens Group's AbbVie position peaked at $488K in Q3 2025.
  • 2,139 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Helen Stephens Group's 13F filing for Q3 2026, filed 14 Oct 2026.